TrialNature medicine2021

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.

Hai-Qiang Mai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.